+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Mesenchymal stem cells: A double-edged sword in radiation-induced lung injury



Mesenchymal stem cells: A double-edged sword in radiation-induced lung injury



Thoracic Cancer 9(2): 208-217



Radiation therapy is an important treatment modality for multiple thoracic malignancies. However, radiation-induced lung injury (RILI), which is the term generally used to describe damage to the lungs caused by exposure to ionizing radiation, remains a critical issue affecting both tumor control and patient quality of life. Despite tremendous effort, there is no current consensus regarding the optimal treatment approach for RILI. Because of a number of functional advantages, including self-proliferation, multi-differentiation, injury foci chemotaxis, anti-inflammation, and immunomodulation, mesenchymal stem cells (MSCs) have been a focus of research for many years. Accumulating evidence indicates the therapeutic potential of transplantation of MSCs derived from adipose tissue, umbilical cord blood, and bone marrow for inflammatory diseases, including RILI. However, reports have also shown that MSCs, including fibrocytes, lung hematopoietic progenitor cells, and ABCG2+ MSCs, actually enhance the progression of lung injuries. These contradictory results suggest that MSCs may have dual effects and that caution should be taken when using MSCs to treat RILI. In this review, we present and discuss recent evidence of the double-edged function of MSCs and provide comments on the prospects of these findings.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065310106

Download citation: RISBibTeXText

PMID: 29235254

DOI: 10.1111/1759-7714.12573


Related references

Mesenchymal stem cells and their mitochondrial transfer: a double-edged sword. Bioscience Reports 39(5):, 2019

Modulatory effects of mesenchymal stem cells on leucocytes and leukemic cells: A double-edged sword?. Blood Cells Molecules and Diseases 55(4): 351-357, 2015

Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells. Tumour Biology 37(9): 11679-11689, 2016

Double-edged sword of mesenchymal stem cells: Cancer-promoting versus therapeutic potential. Cancer Science 108(10): 1939-1946, 2017

NLRP3, a Double-edged Sword in Lung Injury Diseases. Inflammation 38(5): 1855-1856, 2015

Akt: a double-edged sword for hematopoietic stem cells. Cell Cycle 9(7): 1223-1224, 2010

Mesenchymal Stem Cells for Recovery From Radiation-induced Lung Injury. International Journal of Radiation Oncology*biology*physics 84(3): S679-S680, 2012

Mesenchymal Stem Cells Adopt Lung Cell Phenotype in Normal and Radiation-induced Lung Injury Conditions. Applied Immunohistochemistry and Molecular Morphology 24(4): 283-295, 2016

Hypoxia signaling in hematopoietic stem cells: a double-edged sword. Cell Stem Cell 7(3): 276-278, 2010

Gene-modified Mesenchymal Stem Cells Protect Against Radiation-induced Lung Injury. Molecular Therapy 21(2): 456-465, 2013

Regulatory T cells in central nervous system injury: a double-edged sword. Journal of Immunology 193(10): 5013-5022, 2014

Oncogenic Ras: A double-edged sword for human epidermal stem and transient amplifying cells. Small Gtpases 7(3): 147-155, 2016

Stem cells and anti-aging genes: double-edged sword-do the same job of life extension. Stem Cell Research and Therapy 9(1): 3, 2018

Therapeutic effects of bone marrow-derived mesenchymal stem cells on radiation-induced lung injury. Oncology Reports 35(2): 731-738, 2016

Inflammation and Inflammatory Cells in Myocardial Infarction and Reperfusion Injury: A Double-Edged Sword. Clinical Medicine Insights. Cardiology 10: 79-84, 2016